 An increase in tissue perfusion, and an
improvement in the microcirculation was found in the
sulodexide group.308
A prospective, multicenter, RCT assessed sulodexide as
adjunctive treatment to the sclerotherapy. Group A (n ¼
354 patients) received sulodexide twice a day for 7 days
before sclerotherapy and group B (n ¼ 366 patients